AVIPERO is developing unique allosteric modulators of integrins for Tissue repair and age-related diseases.
Company Details
- Employees
- 2
- Founded
- 2023
- Address
- Wilmington, Delaware, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.avipero.co.uk
- Keywords
- Drug Development, Integrin, Tissue Repair, COPD, Arthritis, Parkinson's Disease, Allosteric modulator, Regenrative Medicine, metastatic breast cancer, cancer.
- HQ
- Wilmington, Delaware
Avipero Questions
Avipero's website is http://www.avipero.co.uk
Avipero's LinkedIn profile is https://www.linkedin.com/company/avipero-inc
Avipero has
2 employees.
View email and phone details for 2
employees at Avipero.
Avipero's industry is
Biotechnology Research
Avipero's top competitors are
Mironid® Limited,
Avipero Bio,
Invizius,
Ameripath,
Leadxpro Ag,
Caldan Therapeutics,
Parkure,
Nodus Oncology,
Neurocentrx Pharma Ltd.,
Aten Therapeutics Ltd.
Avipero's categories are Biotechnology Research
Avipero's founding year is 2023
